Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Black Diamond Therapeutics (BDTX) Cash & Current Investments: 2018-2020

Historic Cash & Current Investments for Black Diamond Therapeutics (BDTX) over the last 3 years, with Dec 2020 value amounting to $315.1 million.

  • Black Diamond Therapeutics' Cash & Current Investments fell 29.44% to $235.0 million in Q3 2021 from the same period last year, while for Sep 2021 it was $1.1 billion, marking a year-over-year increase of 5.16%. This contributed to the annual value of $315.1 million for FY2020, which is 103.71% up from last year.
  • As of FY2020, Black Diamond Therapeutics' Cash & Current Investments stood at $315.1 million, which was up 103.71% from $154.7 million recorded in FY2019.
  • Black Diamond Therapeutics' 5-year Cash & Current Investments high stood at $315.1 million for FY2020, and its period low was $51.7 million during FY2018.
  • Moreover, its 3-year median value for Cash & Current Investments was $154.7 million (2019), whereas its average is $173.8 million.
  • Data for Black Diamond Therapeutics' Cash & Current Investments shows a peak YoY skyrocketed of 199.39% (in 2019) over the last 5 years.
  • Yearly analysis of 3 years shows Black Diamond Therapeutics' Cash & Current Investments stood at $51.7 million in 2018, then skyrocketed by 199.39% to $154.7 million in 2019, then surged by 103.71% to $315.1 million in 2020.